Heterozygous and homozygous factor H deficiency states in a Dutch family. 1996

C A Fijen, and E J Kuijper, and M Te Bulte, and M M van de Heuvel, and A C Holdrinet, and R B Sim, and M R Daha, and J Dankert
Department of Medical Microbiology, University of Amsterdam, The Netherlands.

Factor H, a 150-kD protein, is an important down-regulating protein of the alternative pathway of the complement system. Presently, only 15 persons, representing seven families, have been described with homozygous factor H deficiency. Deficiency of this protein, inherited as an autosomal recessive trait and resulting in uncontrolled breakdown of C3, results in depletion of components of the alternative pathway (factor B, properdin) and of the terminal pathway (C5), and is associated with the onset of bacterial infections, glomerulonephritis and systemic lupus erythematosus (SLE). The proband of the family in this study suffered from subacute cutaneous lupus erythematosus and had had meningococcal meningitis due to serogroup X. She had a complete factor H deficiency at the protein level as determined by Western blotting. Among 21 relatives of the proband studied, encompassing three generations, 10 had low factor H levels, including the two children of the proband, indicating a heterozygous factor H deficiency state. In serum samples of the proband and 11 relatives prospectively studied, a strong correlation of factor H levels with C3, C3 haemolytic activity, factor B and properdin levels (P < 0.0001) was found. Alternative pathway protein levels were significantly lower (Mann-Whitney test; Z values 3.6-2.7) in sera from the four heterozygous relatives studied than in sera from the seven non-deficient relatives. In addition, a defect of the 37/42-kD H-related protein was found in the proband and two of 21 relatives, compared with four of 40 controls. A defect of the 24/29-kD H-related protein was present in one of 21 relatives studied and in none of the 40 controls.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009426 Netherlands Country located in EUROPE. It is bordered by the NORTH SEA, BELGIUM, and GERMANY. Constituent areas are Aruba, Curacao, and Sint Maarten, formerly included in the NETHERLANDS ANTILLES. Holland,Kingdom of the Netherlands
D010375 Pedigree The record of descent or ancestry, particularly of a particular condition or trait, indicating individual family members, their relationships, and their status with respect to the trait or condition. Family Tree,Genealogical Tree,Genealogic Tree,Genetic Identity,Identity, Genetic,Family Trees,Genealogic Trees,Genealogical Trees,Genetic Identities,Identities, Genetic,Tree, Family,Tree, Genealogic,Tree, Genealogical,Trees, Family,Trees, Genealogic,Trees, Genealogical
D005260 Female Females
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006720 Homozygote An individual in which both alleles at a given locus are identical. Homozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015941 Complement Hemolytic Activity Assay A screening assay for circulating COMPLEMENT PROTEINS. Diluted SERUM samples are added to antibody-coated ERYTHROCYTES and the percentage of cell lysis is measured. The values are expressed by the so called CH50, in HEMOLYTIC COMPLEMENT units per milliliter, which is the dilution of serum required to lyse 50 percent of the erythrocytes in the assay. CH50 Assay,Complement H50,Hemolytic Titration Assay,Serum Complement Titer,Total Hemolytic Complement,Whole Complement Titer,CH(50),Assay, CH50,Assay, Hemolytic Titration,Assays, CH50,Assays, Hemolytic Titration,CH50 Assays,Complement H50s,Complement, Total Hemolytic,Complements, Total Hemolytic,Hemolytic Complement, Total,Hemolytic Complements, Total,Hemolytic Titration Assays,Serum Complement Titers,Titer, Serum Complement,Titer, Whole Complement,Titers, Serum Complement,Titers, Whole Complement,Titration Assay, Hemolytic,Titration Assays, Hemolytic,Total Hemolytic Complements,Whole Complement Titers
D017242 Complement Factor H An important soluble regulator of the alternative pathway of complement activation (COMPLEMENT ACTIVATION PATHWAY, ALTERNATIVE). It is a 139-kDa glycoprotein expressed by the liver and secreted into the blood. It binds to COMPLEMENT C3B and makes iC3b (inactivated complement 3b) susceptible to cleavage by COMPLEMENT FACTOR I. Complement factor H also inhibits the association of C3b with COMPLEMENT FACTOR B to form the C3bB proenzyme, and promotes the dissociation of Bb from the C3bBb complex (COMPLEMENT C3 CONVERTASE, ALTERNATIVE PATHWAY). Factor H,Factor H, Complement

Related Publications

C A Fijen, and E J Kuijper, and M Te Bulte, and M M van de Heuvel, and A C Holdrinet, and R B Sim, and M R Daha, and J Dankert
January 1988, Journal of clinical immunology,
C A Fijen, and E J Kuijper, and M Te Bulte, and M M van de Heuvel, and A C Holdrinet, and R B Sim, and M R Daha, and J Dankert
January 1976, Acta haematologica,
C A Fijen, and E J Kuijper, and M Te Bulte, and M M van de Heuvel, and A C Holdrinet, and R B Sim, and M R Daha, and J Dankert
January 1985, Haemostasis,
C A Fijen, and E J Kuijper, and M Te Bulte, and M M van de Heuvel, and A C Holdrinet, and R B Sim, and M R Daha, and J Dankert
May 1992, Thrombosis and haemostasis,
C A Fijen, and E J Kuijper, and M Te Bulte, and M M van de Heuvel, and A C Holdrinet, and R B Sim, and M R Daha, and J Dankert
August 1976, Blood,
C A Fijen, and E J Kuijper, and M Te Bulte, and M M van de Heuvel, and A C Holdrinet, and R B Sim, and M R Daha, and J Dankert
April 2000, Journal of thrombosis and thrombolysis,
C A Fijen, and E J Kuijper, and M Te Bulte, and M M van de Heuvel, and A C Holdrinet, and R B Sim, and M R Daha, and J Dankert
September 2009, Haemophilia : the official journal of the World Federation of Hemophilia,
C A Fijen, and E J Kuijper, and M Te Bulte, and M M van de Heuvel, and A C Holdrinet, and R B Sim, and M R Daha, and J Dankert
December 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation,
C A Fijen, and E J Kuijper, and M Te Bulte, and M M van de Heuvel, and A C Holdrinet, and R B Sim, and M R Daha, and J Dankert
October 2009, Clinical and experimental nephrology,
C A Fijen, and E J Kuijper, and M Te Bulte, and M M van de Heuvel, and A C Holdrinet, and R B Sim, and M R Daha, and J Dankert
June 2020, European journal of medical genetics,
Copied contents to your clipboard!